Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Prophylaxis of Overt Hepatic Encephalopathy in Cirrhosis: a Randomized Controlled Trial of Colistin Versus Lactulose

NCT05279586 is registered in ClinicalTrials.gov with Madonna Magdy Fahmy as lead sponsor.

NCT NCT05279586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05279586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Prophylaxis of Overt Hepatic Encephalopathy in Cirrhosis: a Randomized Controlled Trial of Colistin Versus Lactulose
Lead sponsor
Madonna Magdy Fahmy
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2022
Completion date
March 31, 2023
Enrollment
316 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic encephalopathy